BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 31078136)

  • 1. Implications of altered NAD metabolism in metabolic disorders.
    Okabe K; Yaku K; Tobe K; Nakagawa T
    J Biomed Sci; 2019 May; 26(1):34. PubMed ID: 31078136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.
    Braidy N; Berg J; Clement J; Khorshidi F; Poljak A; Jayasena T; Grant R; Sachdev P
    Antioxid Redox Signal; 2019 Jan; 30(2):251-294. PubMed ID: 29634344
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases.
    Hikosaka K; Yaku K; Okabe K; Nakagawa T
    Nutr Neurosci; 2021 May; 24(5):371-383. PubMed ID: 31280708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD
    Yoshino J; Baur JA; Imai SI
    Cell Metab; 2018 Mar; 27(3):513-528. PubMed ID: 29249689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health.
    Alegre GFS; Pastore GM
    Curr Nutr Rep; 2023 Sep; 12(3):445-464. PubMed ID: 37273100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.
    Ugamraj HS; Dang K; Ouisse LH; Buelow B; Chini EN; Castello G; Allison J; Clarke SC; Davison LM; Buelow R; Deng R; Iyer S; Schellenberger U; Manika SN; Bijpuria S; Musnier A; Poupon A; Cuturi MC; van Schooten W; Dalvi P
    MAbs; 2022; 14(1):2095949. PubMed ID: 35867844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Nmnat3 efficiently increases NAD and NGD levels and ameliorates age-associated insulin resistance.
    Gulshan M; Yaku K; Okabe K; Mahmood A; Sasaki T; Yamamoto M; Hikosaka K; Usui I; Kitamura T; Tobe K; Nakagawa T
    Aging Cell; 2018 Aug; 17(4):e12798. PubMed ID: 29901258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders.
    Srivastava S
    Clin Transl Med; 2016 Dec; 5(1):25. PubMed ID: 27465020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of NAD
    Kang BE; Choi JY; Stein S; Ryu D
    Eur J Clin Invest; 2020 Oct; 50(10):e13334. PubMed ID: 32594513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAD+ and sirtuins in aging and disease.
    Imai S; Guarente L
    Trends Cell Biol; 2014 Aug; 24(8):464-71. PubMed ID: 24786309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects.
    Okabe K; Yaku K; Uchida Y; Fukamizu Y; Sato T; Sakurai T; Tobe K; Nakagawa T
    Front Nutr; 2022; 9():868640. PubMed ID: 35479740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD).
    Yaku K; Okabe K; Gulshan M; Takatsu K; Okamoto H; Nakagawa T
    Sci Rep; 2019 Sep; 9(1):13102. PubMed ID: 31511627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD
    Yaku K; Nakagawa T
    Antioxid Redox Signal; 2023 Dec; 39(16-18):1133-1149. PubMed ID: 37335049
    [No Abstract]   [Full Text] [Related]  

  • 14. NAD⁺ metabolism: a therapeutic target for age-related metabolic disease.
    Mouchiroud L; Houtkooper RH; Auwerx J
    Crit Rev Biochem Mol Biol; 2013; 48(4):397-408. PubMed ID: 23742622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer.
    Navas LE; Carnero A
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.
    Ratajczak J; Joffraud M; Trammell SA; Ras R; Canela N; Boutant M; Kulkarni SS; Rodrigues M; Redpath P; Migaud ME; Auwerx J; Yanes O; Brenner C; Cantó C
    Nat Commun; 2016 Oct; 7():13103. PubMed ID: 27725675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high-fat diet.
    Zhang Y; Zhu W; Wang M; Xi P; Wang H; Tian D
    IUBMB Life; 2023 Jun; 75(6):548-562. PubMed ID: 36785893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD⁺ in aging, metabolism, and neurodegeneration.
    Verdin E
    Science; 2015 Dec; 350(6265):1208-13. PubMed ID: 26785480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule.
    Elhassan YS; Philp AA; Lavery GG
    J Endocr Soc; 2017 Jul; 1(7):816-835. PubMed ID: 29264533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory Effects of NAD
    Zhang N; Sauve AA
    Prog Mol Biol Transl Sci; 2018; 154():71-104. PubMed ID: 29413178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.